We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Instem Plc | LSE:INS | London | Ordinary Share | GB00B3TQCK30 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 830.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMINS
RNS Number : 6280Y
Instem plc
07 March 2017
Instem plc
Notice of Results
Instem plc (AIM: INS), a leading provider of IT solutions to the global early development healthcare market, will announce full year results for the year ended 31 December 2016 on Tuesday 28 March 2017.
Management will be hosting a presentation for analysts on the day of the results at 9.30am at the offices of Walbrook PR, 4 Lombard Street, London, EC3V 9HD.
Analysts wishing to attend the presentation should register their interest by emailing instem@walbrookpr.com or by telephoning 020 7933 8780.
For further information, please contact:
Hot Features
Premium
Instem plc Tel: +44 (0) 1785 825
600
Phil Reason, CEO www.instem.com
Nigel Goldsmith, CFO
N+1 Singer (Nominated Tel: +44 (0) 20 7496 3000
Adviser & Broker)
Richard Lindley
Nick Owen
James White
Walbrook PR Ltd Tel: +44 (0) 20 7933 8780
or
Paul Cornelius instem@walbrookpr.com
Sam Allen
Helen Cresswell
Paul Whittington
About Instem
Instem is a leading supplier of IT applications and services to the early development healthcare market delivering compelling solutions for data collection, analysis and regulatory submissions management. Instem solutions are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organisations for data-driven decision making leading to safer, more effective products.
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information. Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India. To learn more about Instem solutions and its mission, please visit www.instem.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORFMGGFZVDGNZM
(END) Dow Jones Newswires
March 07, 2017 02:02 ET (07:02 GMT)
1 Year Instem Chart |
1 Month Instem Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
